Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk

British Journal of Cancer

Volumn 108, Issue 11, 2013, Pages 2372-2380

  Wang, J ^a   Wu, X ^a   Kamat, A ^a   Grossman, H Barton ^a   Dinney, C P ^a   Lin, J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Bladder cancer; Fluid intake; Genetic polymorphism; UDP glucuronosyltransferase

Indexed keywords

GLUCURONOSYLTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BEER; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; COFFEE; CONTROLLED STUDY; FEMALE; FLUID INTAKE; GENETIC VARIABILITY; GENOTYPE; HERBAL TEA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIQUID; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIGENE FAMILY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOFT DRINK; WINE; AGED; BLADDER TUMOR; DRINKING; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR; TRANSITIONAL CELL CARCINOMA; UNITED STATES;

AGED; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; DRINKING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TEXAS; URINARY BLADDER NEOPLASMS;

EID: 84884170888     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.190     Document Type: Article

References (45)

1. Albanes D (1987) Caloric intake, body weight, and cancer: a review. Nutr Cancer 9(4): 199-217.
2. Altieri A, La Vecchia C, Negri E (2003) Fluid intake and risk of bladder and other cancers. Eur J Clin Nutr 57(Suppl 2): S59-S68.
3. Block G, Thompson FE, Hartman AM, Larkin FA, Guire KE (1992) Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 92(6): 686-693.
4. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M (2009) Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev 8(3): CD005004.
5. Brinkman M, Zeegers MP (2008) Nutrition, total fluid and bladder cancer. Scand J Urol Nephrol Suppl 218: 25-36.
6. Bruemmer B, White E, Vaughan TL, Cheney CL (1997) Fluid intake and the incidence of bladder cancer among middle-aged men and women in a three-county area of western Washington. Nutr Cancer 29(2): 163-168.
7. Bushman JL (1998) Green tea and cancer in humans: a review of the literature. Nutr Cancer 31(3): 151-159.
8. Cantor KP, Hoover R, Hartge P, Mason TJ, Silverman DT, Altman R, Austin DF, Child MA, Key CR, Marrett LD (1987) Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst 79(6): 1269-1279.
9. Claude J, Kunze E, Frentzel-Beyme R, Paczkowski K, Schneider J, Schubert H (1986) Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 124(4): 578-589.
10. Desai AA, Innocenti F, Ratain MJ (2003) UGT pharmacogenomics: implications for cancer risk and cancer therapeutics. Pharmacogenetics 13(8): 517-523.
11. Geoffroy-Perez B, Cordier S (2001) Fluid consumption and the risk of bladder cancer: results of a multicenter case-control study. Int J Cancer 93(6): 880-887.
12. Giuliani L, Ciotti M, Stoppacciaro A, Pasquini A, Silvestri I, De Matteis A, Frati L, Agliano AM (2005) UDP-glucuronosyltransferases 1A expression in human urinary bladder and colon cancer by immunohistochemistry. Oncol Rep 13(2): 185-191.
13. Giuliani L, Gazzaniga P, Caporuscio F, Ciotti M, Frati L, Agliano AM (2001) Can down-regulation of UDP-glucuronosyltransferases in the urinary bladder tissue impact the risk of chemical carcinogenesis? Int J Cancer 91(1): 141-143.
14. Guillemette C (2003) Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 3(3): 136-158.
15. Higdon JV, Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46(2): 101-123.
16. Iida K, Mimura J, Itoh K, Ohyama C, Fujii-Kuriyama Y, Shimazui T, Akaza H, Yamamoto M (2010) Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBNinduced urinary bladder carcinogenesis in mice. J Biochem 147(3): 353-360.
17. Iyanagi T (2007) Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification. Int Rev Cytol 260: 35-112.
18. Jiang X, Castelao JE, Groshen S, Cortessis VK, Ross RK, Conti DV, Gago-Dominguez M (2007) Alcohol consumption and risk of bladder cancer in Los Angeles County. Int J Cancer 121(4): 839-845.
19. Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata DK, Conti DV, Gago-Dominguez M (2008) Water intake and bladder cancer risk in Los Angeles County. Int J Cancer 123(7): 1649-1656.
20. King CD, Rios GR, Green MD, Tephly TR (2000) UDP-glucuronosyltransferases. Curr Drug Metab 1(2): 143-161.
21. Kuo PL, Hsu YL (2008) The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing Fas/membrane bound Fas ligand-mediated apoptotic pathway. Mol Nutr Food Res 52(4): 408-418.
22. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane S. Japan Public Health Center Study G (2009) Coffee, green tea, and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: a prospective study in Japan. Cancer Sci 100(2): 284-291.
23. Lampe JW (2007) Diet, genetic polymorphisms, detoxification, and health risks. Altern Ther Health Med 13(2): S108-S111.
24. Lin GF, Guo WC, Chen JG, Qin YQ, Golka K, Xiang CQ, Ma QW, Lu DR, Shen JH (2005) An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidineexposed workers in China. Toxicol Sci 85(1): 502-506.
25. Lin J, Wang J, Greisinger AJ, Grossman HB, Forman MR, Dinney CP, Hawk ET, Wu X (2010) Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer. Cancer Prev Res 3(4): 505-517.
26. Mackenzie PI, Gregory PA, Lewinsky RH, Yasmin SN, Height T, McKinnon RA, Gardner-Stephen DA (2005) Polymorphic variations in the expression of the chemical detoxifying UDP glucuronosyltransferases. Toxicol Appl Pharmacol 207(2 Suppl): 77-83.
27. Michaud DS, Kogevinas M, Cantor KP, Villanueva CM, Garcia-Closas M, Rothman N, Malats N, Real FX, Serra C, Garcia-Closas R, Tardon A, Carrato A, Dosemeci M, Silverman DT (2007) Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer. Environ Health Perspect 115(11): 1569-1572.
28. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GC, Willett WC, Giovannucci EL (1999) Fluid intake and the risk of bladder cancer in men. N Engl J Med 340(18): 1390-1397.
29. Mueller NT, Odegaard A, Anderson K, Yuan JM, Gross M, Koh WP, Pereira MA (2010) Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 19(2): 447-455.
30. Nkondjock A (2009) Coffee consumption and the risk of cancer: an overview. Cancer Lett 277(2): 121-125.
31. Odegaard AO, Koh WP, Arakawa K, Yu MC, Pereira MA (2010) Soft drink and juice consumption and risk of physician-diagnosed incident type 2 diabetes: the Singapore Chinese Health Study. Am J Epidemiol 171(6): 701-708.
32. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006) Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol 3(6): 327-340.
33. Pelucchi C, La Vecchia C (2009) Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies. Eur J Cancer Prev 18(1): 62-68.
34. Pelucchi C, Tavani A, La Vecchia C (2008) Coffee and alcohol consumption and bladder cancer. Scand J Urol Nephrol Suppl 42(218): 37-44.
35. Ros MM, Bas Bueno-de-Mesquita HB, Buchner FL, Aben KK, Kampman E, Egevad L, Overvad K, Tjonneland A, Roswall N, Clavel-Chapelon F, Kaaks R, Chang-Claude J, Boeing H, Weikert S, Trichopoulou A, Orfanos P, Stasinopulou G, Saieva C, Krogh V, Vineis P, Tumino R, Mattiello A, Peeters PH, van Duijnhoven FJ, Lund E, Gram IT, Chirlaque MD, Barricarte A, Rodriguez L, Molina E, Gonzalez C, Dorronsoro M, Manjer J, Ehrnstrom R, Ljungberg B, Allen NE, Roddam AW, Khaw KT, Wareham N, Boffetta P, Slimani N, Michaud DS, Kiemeney LA, Riboli E (2011) Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 128(11): 2695-2708.
36. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole Jr. G, Grubb 3rd R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D García-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni Jr. JF, Silverman DT, Chanock SJ (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42(11): 978-984.
37. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4): 212-236.
38. Vena JE, Graham S, Freudenheim J, Marshall J, Zielezny M, Swanson M, Sufrin G (1993) Drinking water, fluid intake, and bladder cancer in western New York. Arch Environ Health 48(3): 191-198.
39. Villanueva CM, Cantor KP, Cordier S, Jaakkola JJ, King WD, Lynch CF, Porru S, Kogevinas M (2004) Disinfection byproducts and bladder cancer: a pooled analysis. Epidemiology 15(3): 357-367.
40. Villanueva CM, Cantor KP, King WD, Jaakkola JJ, Cordier S, Lynch CF, Porru S, Kogevinas M (2006) Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer 118(8): 2040-2047.
41. Villanueva CM, Silverman DT, Murta-Nascimento C, Malats N, Garcia-Closas M, Castro F, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Real FX, Dosemeci M, Kogevinas M (2009) Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer Causes Control 20(1): 121-127.
42. Wu X, Lin J, Grossman HB, Huang M, Gu J, Etzel CJ, Amos CI, Dinney CP, Spitz MR (2007) Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol 25(31): 4974-4981.
43. Wu X, Ros MM, Gu J, Kiemeney L (2008) Epidemiology and genetic susceptibility to bladder cancer. BJU Int 102(9 Pt B): 1207-1215.
44. Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9(6): 429-439.
45. Zeegers MP, Dorant E, Goldbohm RA, van den Brandt PA (2001) Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study. Cancer Causes Control 12(3): 231-238.